市场调查报告书
商品编码
1597172
欧洲临床参考实验室市场预测至 2031 年 - 区域分析 - 按服务提供者(医院、独立和诊所)和应用(实验室医学、临床试验等)Europe Clinical Reference Laboratory Market Forecast to 2031 - Regional Analysis - by Service Provider (Hospital-Based, Standalone, and Clinic-Based) and Application (Laboratory Medicine, Clinical Trials, and Others) |
2023年欧洲临床参考实验室市值为134.3117亿美元,预计2031年将达到216.700亿美元;预计2023年至2031年复合年增长率为6.2%。
临床试验数量的增加推动了欧洲临床参考实验室市场
临床试验有助于评估新的治疗或预防方法,例如新的药物、饮食或医疗技术是否安全有效。这些试验主要在药物开发阶段进行。根据欧洲药品管理局统计,欧盟(EU)每年批准约4,000项临床试验,其中製药业约占60%。由于慢性病的盛行率不断增加,临床试验的数量不断增加,以开发各种有效的治疗方法。临床试验正逐渐变得复杂,因为对研究型组织中发生的操作的正确执行和监督变得至关重要。研究型组织在开发产品时外包临床试验,以避免因执行不当而出现错误。参考实验室以其积极主动的方式跟上科学技术的进步而闻名。参考实验室迅速采用和整合新的诊断仪器、设备和技术,使他们能够评估其潜在的应用和效益。临床参考实验室透过提供廉价且高效的全面临床和比较测试菜单,帮助研究团队成功开展专案。临床参考实验室收集并提供所需的样本,并在其设施中进行必要的测试。这意味着所有服务都可以在同一个屋檐下使用。 Vimta Labs Ltd、Regional Pathology Services 和 Boca Bio 提供商业临床试验服务。因此,临床试验数量的增加正在推动临床参考实验室市场的成长。
欧洲临床参考实验室市场概况
癌症、心血管疾病、神经系统疾病和传染病是德国临床试验中最常研究的疾病。临床研究受惠于德国完善的交通、通讯、能源和公共服务基础设施。根据美国国立卫生研究院 2023 年 12 月发表的一篇文章,德国约有 400 万人患有罕见疾病。罕见疾病具有复杂的临床模式。此类疾病的治疗需要加速试验和快速追踪临床结果。这就是参考实验室发挥关键作用的地方。 2023 年 1 月,Premier Research 与 CENTOGENE 合作,降低罕见疾病临床开发的风险。 Premier Research 在罕见疾病产品开发方面的广泛专业知识将得到 CENTOGENE 生物资料库和多组学参考实验室产生的先进见解的支持。此外,由于慢性病毒性疾病的盛行率不断上升,以及为病毒治疗领域生产新分子以满足未满足条件的需求不断增长,德国对抗感染药物的需求正在显着增长。由于上述因素,预计该国市场将大幅成长。
欧洲临床参考实验室市场收入及 2031 年预测(百万美元)
欧洲临床参考实验室市场细分
欧洲临床参考实验室市场按服务提供者、应用程式和国家分类。
根据服务提供者,欧洲临床参考实验室市场分为医院型、独立型和诊所型。 2023 年,医院细分市场占据最大的市场。
从应用来看,欧洲临床参考实验室市场分为检验医学、临床试验等。 2023 年,检验医学领域占据最大的市场份额。
依国家/地区划分,欧洲临床参考实验室市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。 2023 年,德国在欧洲临床参考实验室市场份额中占据主导地位。
Sonic Healthcare Ltd、UNILABS、Laboratory Corp of America Holdings、Quest Diagnostics Inc、SYNLAB International GmbH 和 Myraid Genetics Inc 是欧洲临床参考实验室市场上的一些领先公司。
The Europe clinical reference laboratory market was valued at US$ 13,431.17 million in 2023 and is expected to reach US$ 21,670.00 million by 2031; it is estimated to register a CAGR of 6.2% from 2023 to 2031.
Increasing Number of Clinical Trials Drives Europe Clinical Reference Laboratory Market
Clinical trials assist in evaluating whether a new treatment or prevention method, such as a new medicine, diet, or medical technology, is safe and effective. The trials are primarily conducted during the drug development phase. According to the European Medicine Agency, in the European Union (EU), ~4,000 clinical trials are approved annually, with the pharmaceutical industry accounting for roughly 60%. Due to the growing prevalence of chronic diseases, the number of clinical trials is increasing to develop various effective treatments. Clinical trials are gradually becoming complex procedures, because proper execution and oversight of the operations occurring in research-based organizations have become crucial. Research-based organizations are outsourcing clinical trials while developing their products to avoid errors due to improper execution. Reference laboratories are well-known for their proactive approach to keeping up with scientific and technological advancements. Reference labs promptly adopt and integrate new diagnostic instruments, equipment, and techniques, allowing them to evaluate their potential applications and benefits. Clinical reference labs help research teams successfully conduct their projects by providing a comprehensive menu of clinical and comparative testing performed inexpensively and efficiently. Clinical reference labs collect and provide the required samples and perform the necessary testing at their facility. That means all the services are available under one roof. Vimta Labs Ltd, Regional Pathology Services, and Boca Bio provide commercial clinical trial services. Thus, the increasing number of clinical trials is driving the clinical reference laboratory market growth.
Europe Clinical Reference Laboratory Market Overview
Cancer, cardiovascular illness, nervous system disorders, and infectious diseases are the most frequently studied conditions in clinical trials in Germany. Clinical research benefits from Germany's well-established transport, communication, energy, and public services infrastructure. According to an article published by the National Institutes of Health in December 2023, ~4 million people had a rare disease in Germany. Rare diseases have complex clinical patterns. Treatments for such diseases need accelerated trials and fast-track clinical outcomes. This is where reference laboratories play a crucial role. In January 2023, Premier Research partnered with CENTOGENE to de-risk rare disease clinical development. Premier Research's extensive expertise in rare disease product development will be supported by advanced insights generated by the CENTOGENE Biodatabank and multiomic reference laboratories. Moreover, the demand for anti-infective agents in Germany is growing significantly, attributed to the increasing prevalence of chronic viral diseases and the growing demand to produce new molecules for viral therapeutic areas to fulfill unmet conditions. The market is expected to grow significantly in the country due to the abovementioned factors.
Europe Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million)
Europe Clinical Reference Laboratory Market Segmentation
The Europe clinical reference laboratory market is categorized into service provider, application, and country.
Based on service provider, the Europe clinical reference laboratory market is segmented into hospital-based, standalone, and clinic-based. The hospital-based segment held the largest market share in 2023.
In terms of application, the Europe clinical reference laboratory market is categorized into laboratory medicine, clinical trials, and others. The laboratory medicine segment held the largest market share in 2023.
By country, the Europe clinical reference laboratory market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe clinical reference laboratory market share in 2023.
Sonic Healthcare Ltd, UNILABS, Laboratory Corp of America Holdings, Quest Diagnostics Inc, SYNLAB International GmbH, and Myraid Genetics Inc are some of the leading companies operating in the Europe clinical reference laboratory market.